NeuroBo Pharmaceuticals Price to Sales Ratio 1970-1969 | MTVA
Historical PS ratio values for NeuroBo Pharmaceuticals (MTVA) over the last 10 years. The current P/S ratio for NeuroBo Pharmaceuticals as of November 29, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| NeuroBo Pharmaceuticals P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
|
0.00 |
|
nan |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.022B |
$0.000B |
|
NeuroBo Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on novel treatments for neurodegenerative diseases. The company's novel lead candidate NB-01 is a drug candidate for diabetic neuropathic pain. NB-02 focuses on the treatment of neurodegenerative diseases. NeuroBo Pharmaceuticals Inc., formerly known as Gemphire Therapeutics Inc., is based in Northville, United States.
|
